News
Are Your Android Apps Crashing? Update WebView Now
If you recently noticed that some of your Android apps were crashing, or weren’t working as they should, you’re not alone. A problem with System WebView, one of Android’s system components, was to blame.
The issue, which was first noticed on Monday, persisted for roughly 7 hours according to Gmail’s Google Workspace dashboard. Until a fix could be made, the company suggested users make use of the desktop interface.
“We are aware of an issue with WebView causing some apps on Android to crash. We are currently working to fully validate the scope and a fix is in progress.” said a Google spokesperson.
Also Read: Tinder Will Soon Let You Background Check Your Matches
The Android System WebView is essentially responsible for allowing Android apps to display web content. Google was quick to notice the issue and says a fix is now available.
To resolve the issue, users are advised to update Google Chrome, as well as Android System WebView to version 89.0.4389.105.
News
Orchid Plans To Find Out What’s Wrong With You Before You’re Born
According to CEO Noor Siddiqui, the company isn’t on a mission to make designer babies, but aims to beat genetic odds and relieve suffering.
Each day, around 400,000 babies are welcomed into the world. However, among those, a growing number will experience some kind of birth defect or inherited disease.
Noor Siddiqui, CEO of Orchid, hopes to “mitigate” unpleasant genetic surprises using genome sequencing technology to reveal a wealth of genetic information on which newborns will grow into healthy adults.
Until 2019, IVF specialists had access to under 1% of the human genome. The tests, called PGT-A and PGT-M, scanned a mere 1,000 data points in a genome comprising around 3 billion bases, offering a very limited dataset compared to the technology used by Orchid.
“Our chromosomes are like chapters in a book that make up the table of contents.” Explained Siddiqui. “[PGT-A and PGT-M tests] only examine the table of contents, whereas what Orchid is doing is like a spellcheck on the entire book.” Orchid’s genome sampling technology assesses “100 times the data, covering many more conditions.” In essence, an Orchid report covers three categories of common genetic issues: monogenic disorders, polygenic conditions, and de-novo mutations.
Also Read: Advancing MENA Health Through AI Vascular Age Analysis
Orchid’s technology raises many questions. Aside from the obvious ethical concerns, data privacy is the most obvious potential issue with the tests. Noor Siddiqui is keen to alleviate any concerns: “No data at Orchid is ever sold to any third parties. Parents are in complete control of their data. If they want to delete the data, we’re happy to delete it off of our servers. If they want to export the data, they can export the data. And if they want us to re-analyze the data, we can re-analyze the data”.
Compared to a lifetime of medical bills, gene therapy, and suffering, Orchid’s genome screening report has the potential to change the future lives of thousands of newborns worldwide.
-
News2 weeks ago
NETGEAR’s Orbi 970 Routers Offer Powerful Wi-Fi 7 Connectivity
-
News2 weeks ago
Adobe Reveals New AI Tools That Will Wow Photoshop Novices
-
News2 weeks ago
Abu Dhabi Developer To Build World’s First Healthy Living Island
-
News2 weeks ago
Samsung Galaxy Ring Wearable Will Launch In Eight Sizes